南玻A(000012.SZ)2021年度淨利潤預增66%–109%
格隆匯1月28日丨南玻A(000012.SZ)公佈,預計2021年度歸屬於上市公司股東的淨利潤12.9億元-16.3億元,同比增長66%–109%;扣除非經常性損益後的淨利潤12億元-15.4億元,同比增長122%–185%。業績變動原因如下:
報吿期內,玻璃市場需求總體向好,產品均價同比有較大幅度上漲;同時,電子玻璃及顯示器件業務整體業績(不考慮計提減值因素)同比迅速提升。
公司前三季度累計已計提資產減值69845萬元,根據實際情況公司擬在第四季度對清遠南玻一期產線技改在建資產,以及商譽和部分涉訴應收款項等資產計提減值準備,預計全年計提減值準備約10.7億元至11.8億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.